Simcere Pharmaceutical Group (SCR: Quote) said it appointed Hongquan Liu as its chief executive officer, or CEO, and executive director of the Board, effective October 8, 2012. Jinsheng Ren will continue to serve as chairman of Simcere.
Between 2000 and 2012, Liu held the positions of director and general manager of Sino-Swed Pharmaceutical Corp. Ltd. Before that, he held the positions of chief financial officer and chief marketing and business officer of Pharmacia & Upjohn (China) Ltd., and general manager of Pharmacia Corp.
In addition, Simcere announced that Dr. Yehong Zhang, who currently serves as its president, will serve as CEO of Simcere MSD (Shanghai) Pharmaceutical Co. Ltd, the newly established joint venture between Simcere and Merck & Co., Inc. (MRK: Quote), effective from October 8, 2012. Dr. Zhang will no longer hold the position of president of Simcere.
Click here to receive FREE breaking news email alerts for Simcere Pharmaceutical Group and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com